Ligand Pharmaceuticals Incorporated (LGND): Price and Financial Metrics
Ligand Pharmaceuticals Incorporated (LGND)
Today's Latest Price: $116.01 USD
5.24 (4.73%)
Updated Jun 3 11:06am
Add LGND to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
LGND Stock Summary
- With a price/sales ratio of 16.17, Ligand Pharmaceuticals Inc has a higher such ratio than 91.98% of stocks in our set.
- Revenue growth over the past 12 months for Ligand Pharmaceuticals Inc comes in at -53.95%, a number that bests just 3.04% of the US stocks we're tracking.
- Ligand Pharmaceuticals Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 33.96%, greater than the shareholder yield of 92.01% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Ligand Pharmaceuticals Inc are KMPH, AKTS, PLUG, LJPC, and NUAN.
- Visit LGND's SEC page to see the company's official filings. To visit the company's web site, go to www.ligand.com.
LGND Daily Price Range
LGND 52-Week Price Range
LGND Stock Price Chart More Charts
LGND Price/Volume Stats
| Current price | $116.01 | 52-week high | $122.08 |
| Prev. close | $110.77 | 52-week low | $57.24 |
| Day low | $111.21 | Volume | 201,226 |
| Day high | $117.80 | Avg. volume | 472,575 |
| 50-day MA | $93.00 | Dividend yield | N/A |
| 200-day MA | $97.87 | Market Cap | 1.86B |
Ligand Pharmaceuticals Incorporated (LGND) Company Bio
Ligand Pharmaceuticals develops therapies that address the unmet medical needs of patients for a range of diseases, including hepatitis, multiple myeloma, muscle wasting, Alzheimers disease, dyslipidemia, diabetes, anemia, epilepsy, focal segmental glomerulosclerosis, and osteoporosis. The company was founded in 1987 and is based in La Jolla, California.
Loading social stream, please wait...